Global and United States Rare Hematology Market Report & Forecast 2024-2031

Report ID: 1838480 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Rare Hematology Revenue in Rare Hematology Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Rare Hematology Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Rare Hematology Market Size for the Year 2017-2028
        1.2.2 Global Rare Hematology Market Size for the Year 2017-2028
    1.3 Rare Hematology Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Rare Hematology in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Rare Hematology Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Rare Hematology Market Dynamics
        1.4.1 Rare Hematology Industry Trends
        1.4.2 Rare Hematology Market Drivers
        1.4.3 Rare Hematology Market Challenges
        1.4.4 Rare Hematology Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Rare Hematology by Type
    2.1 Rare Hematology Market Segment by Type
        2.1.1 Recombinant Factors
        2.1.2 Plasma Derived Factors
    2.2 Global Rare Hematology Market Size by Type (2017, 2022 & 2028)
    2.3 Global Rare Hematology Market Size by Type (2017-2028)
    2.4 United States Rare Hematology Market Size by Type (2017, 2022 & 2028)
    2.5 United States Rare Hematology Market Size by Type (2017-2028)
3 Rare Hematology by Application
    3.1 Rare Hematology Market Segment by Application
        3.1.1 Pediatric
        3.1.2 Adult
    3.2 Global Rare Hematology Market Size by Application (2017, 2022 & 2028)
    3.3 Global Rare Hematology Market Size by Application (2017-2028)
    3.4 United States Rare Hematology Market Size by Application (2017, 2022 & 2028)
    3.5 United States Rare Hematology Market Size by Application (2017-2028)
4 Global Rare Hematology Competitor Landscape by Company
    4.1 Global Rare Hematology Market Size by Company
        4.1.1 Top Global Rare Hematology Companies Ranked by Revenue (2021)
        4.1.2 Global Rare Hematology Revenue by Player (2017-2022)
    4.2 Global Rare Hematology Concentration Ratio (CR)
        4.2.1 Rare Hematology Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Rare Hematology in 2021
        4.2.3 Global Rare Hematology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Rare Hematology Headquarters, Revenue in Rare Hematology Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Rare Hematology Headquarters and Area Served
        4.3.2 Global Rare Hematology Companies Revenue in Rare Hematology Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Rare Hematology Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Rare Hematology Market Size by Company
        4.5.1 Top Rare Hematology Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Rare Hematology Revenue by Players (2020, 2021 & 2022)
5 Global Rare Hematology Market Size by Region
    5.1 Global Rare Hematology Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Rare Hematology Market Size by Region (2017-2028)
        5.2.1 Global Rare Hematology Market Size by Region: 2017-2022
        5.2.2 Global Rare Hematology Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Rare Hematology Market Size YoY Growth 2017-2028
        6.1.2 North America Rare Hematology Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Rare Hematology Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Rare Hematology Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Rare Hematology Market Size YoY Growth 2017-2028
        6.3.2 Europe Rare Hematology Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Rare Hematology Market Size YoY Growth 2017-2028
        6.4.2 Latin America Rare Hematology Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Rare Hematology Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Rare Hematology Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Takeda
        7.1.1 Takeda Company Details
        7.1.2 Takeda Business Overview
        7.1.3 Takeda Rare Hematology Introduction
        7.1.4 Takeda Revenue in Rare Hematology Business (2017-2022)
        7.1.5 Takeda Recent Development
    7.2 Novo Nordisk A/S
        7.2.1 Novo Nordisk A/S Company Details
        7.2.2 Novo Nordisk A/S Business Overview
        7.2.3 Novo Nordisk A/S Rare Hematology Introduction
        7.2.4 Novo Nordisk A/S Revenue in Rare Hematology Business (2017-2022)
        7.2.5 Novo Nordisk A/S Recent Development
    7.3 Pfizer Inc.
        7.3.1 Pfizer Inc. Company Details
        7.3.2 Pfizer Inc. Business Overview
        7.3.3 Pfizer Inc. Rare Hematology Introduction
        7.3.4 Pfizer Inc. Revenue in Rare Hematology Business (2017-2022)
        7.3.5 Pfizer Inc. Recent Development
    7.4 Bayer Healthcare AG
        7.4.1 Bayer Healthcare AG Company Details
        7.4.2 Bayer Healthcare AG Business Overview
        7.4.3 Bayer Healthcare AG Rare Hematology Introduction
        7.4.4 Bayer Healthcare AG Revenue in Rare Hematology Business (2017-2022)
        7.4.5 Bayer Healthcare AG Recent Development
    7.5 CSL Behring LLC
        7.5.1 CSL Behring LLC Company Details
        7.5.2 CSL Behring LLC Business Overview
        7.5.3 CSL Behring LLC Rare Hematology Introduction
        7.5.4 CSL Behring LLC Revenue in Rare Hematology Business (2017-2022)
        7.5.5 CSL Behring LLC Recent Development
    7.6 Biogen Inc.
        7.6.1 Biogen Inc. Company Details
        7.6.2 Biogen Inc. Business Overview
        7.6.3 Biogen Inc. Rare Hematology Introduction
        7.6.4 Biogen Inc. Revenue in Rare Hematology Business (2017-2022)
        7.6.5 Biogen Inc. Recent Development
    7.7 Alexion Pharmaceuticals
        7.7.1 Alexion Pharmaceuticals Company Details
        7.7.2 Alexion Pharmaceuticals Business Overview
        7.7.3 Alexion Pharmaceuticals Rare Hematology Introduction
        7.7.4 Alexion Pharmaceuticals Revenue in Rare Hematology Business (2017-2022)
        7.7.5 Alexion Pharmaceuticals Recent Development
    7.8 Celgene Corporation
        7.8.1 Celgene Corporation Company Details
        7.8.2 Celgene Corporation Business Overview
        7.8.3 Celgene Corporation Rare Hematology Introduction
        7.8.4 Celgene Corporation Revenue in Rare Hematology Business (2017-2022)
        7.8.5 Celgene Corporation Recent Development
    7.9 Amgen Inc.
        7.9.1 Amgen Inc. Company Details
        7.9.2 Amgen Inc. Business Overview
        7.9.3 Amgen Inc. Rare Hematology Introduction
        7.9.4 Amgen Inc. Revenue in Rare Hematology Business (2017-2022)
        7.9.5 Amgen Inc. Recent Development
    7.10 PRA Health Sciences
        7.10.1 PRA Health Sciences Company Details
        7.10.2 PRA Health Sciences Business Overview
        7.10.3 PRA Health Sciences Rare Hematology Introduction
        7.10.4 PRA Health Sciences Revenue in Rare Hematology Business (2017-2022)
        7.10.5 PRA Health Sciences Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Rare Hematology Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Rare Hematology Market Trends
    Table 3. Rare Hematology Market Drivers
    Table 4. Rare Hematology Market Challenges
    Table 5. Rare Hematology Market Restraints
    Table 6. Global Rare Hematology Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Rare Hematology Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Rare Hematology Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Rare Hematology Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Rare Hematology Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Rare Hematology Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Rare Hematology Revenue Share by Player, 2017-2022
    Table 13. Global Rare Hematology Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Rare Hematology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Hematology as of 2021)
    Table 15. Top Players of Rare Hematology in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Rare Hematology Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Rare Hematology Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Rare Hematology Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Rare Hematology Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Rare Hematology Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Rare Hematology Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Rare Hematology Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Rare Hematology Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Rare Hematology Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Rare Hematology Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Rare Hematology Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Rare Hematology Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Rare Hematology Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Takeda Company Details
    Table 31. Takeda Business Overview
    Table 32. Takeda Rare Hematology Product
    Table 33. Takeda Revenue in Rare Hematology Business (2017-2022) & (US$ Million)
    Table 34. Takeda Recent Development
    Table 35. Novo Nordisk A/S Company Details
    Table 36. Novo Nordisk A/S Business Overview
    Table 37. Novo Nordisk A/S Rare Hematology Product
    Table 38. Novo Nordisk A/S Revenue in Rare Hematology Business (2017-2022) & (US$ Million)
    Table 39. Novo Nordisk A/S Recent Development
    Table 40. Pfizer Inc. Company Details
    Table 41. Pfizer Inc. Business Overview
    Table 42. Pfizer Inc. Rare Hematology Product
    Table 43. Pfizer Inc. Revenue in Rare Hematology Business (2017-2022) & (US$ Million)
    Table 44. Pfizer Inc. Recent Development
    Table 45. Bayer Healthcare AG Company Details
    Table 46. Bayer Healthcare AG Business Overview
    Table 47. Bayer Healthcare AG Rare Hematology Product
    Table 48. Bayer Healthcare AG Revenue in Rare Hematology Business (2017-2022) & (US$ Million)
    Table 49. Bayer Healthcare AG Recent Development
    Table 50. CSL Behring LLC Company Details
    Table 51. CSL Behring LLC Business Overview
    Table 52. CSL Behring LLC Rare Hematology Product
    Table 53. CSL Behring LLC Revenue in Rare Hematology Business (2017-2022) & (US$ Million)
    Table 54. CSL Behring LLC Recent Development
    Table 55. Biogen Inc. Company Details
    Table 56. Biogen Inc. Business Overview
    Table 57. Biogen Inc. Rare Hematology Product
    Table 58. Biogen Inc. Revenue in Rare Hematology Business (2017-2022) & (US$ Million)
    Table 59. Biogen Inc. Recent Development
    Table 60. Alexion Pharmaceuticals Company Details
    Table 61. Alexion Pharmaceuticals Business Overview
    Table 62. Alexion Pharmaceuticals Rare Hematology Product
    Table 63. Alexion Pharmaceuticals Revenue in Rare Hematology Business (2017-2022) & (US$ Million)
    Table 64. Alexion Pharmaceuticals Recent Development
    Table 65. Celgene Corporation Company Details
    Table 66. Celgene Corporation Business Overview
    Table 67. Celgene Corporation Rare Hematology Product
    Table 68. Celgene Corporation Revenue in Rare Hematology Business (2017-2022) & (US$ Million)
    Table 69. Celgene Corporation Recent Development
    Table 70. Amgen Inc. Company Details
    Table 71. Amgen Inc. Business Overview
    Table 72. Amgen Inc. Rare Hematology Product
    Table 73. Amgen Inc. Revenue in Rare Hematology Business (2017-2022) & (US$ Million)
    Table 74. Amgen Inc. Recent Development
    Table 75. PRA Health Sciences Company Details
    Table 76. PRA Health Sciences Business Overview
    Table 77. PRA Health Sciences Rare Hematology Product
    Table 78. PRA Health Sciences Revenue in Rare Hematology Business (2017-2022) & (US$ Million)
    Table 79. PRA Health Sciences Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rare Hematology Product Picture
    Figure 2. Global Rare Hematology Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Rare Hematology Market Size 2017-2028 (US$ Million)
    Figure 4. United States Rare Hematology Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Rare Hematology Market Size 2017-2028 (US$ Million)
    Figure 6. United States Rare Hematology Market Share in Global 2017-2028
    Figure 7. Rare Hematology Report Years Considered
    Figure 8. Product Picture of Recombinant Factors
    Figure 9. Product Picture of Plasma Derived Factors
    Figure 10. Global Rare Hematology Market Share by Type in 2022 & 2028
    Figure 11. Global Rare Hematology Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Rare Hematology Market Share by Type (2017-2028)
    Figure 13. United States Rare Hematology Market Share by Type in 2022 & 2028
    Figure 14. United States Rare Hematology Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Rare Hematology Market Share by Type (2017-2028)
    Figure 16. Product Picture of Pediatric
    Figure 17. Product Picture of Adult
    Figure 18. Global Rare Hematology Market Share by Application in 2022 & 2028
    Figure 19. Global Rare Hematology Market Size by Application (2017-2028) & (US$ Million)
    Figure 20. Global Rare Hematology Market Share by Application (2017-2028)
    Figure 21. United States Rare Hematology Market Share by Application in 2022 & 2028
    Figure 22. United States Rare Hematology Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. United States Rare Hematology Market Share by Application (2017-2028)
    Figure 24. North America Rare Hematology Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 25. U.S. Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 26. Canada Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Europe Rare Hematology Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. Germany Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. France Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. U.K. Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Italy Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Russia Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Rare Hematology Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. China Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Japan Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. South Korea Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. India Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Australia Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Taiwan Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Indonesia Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Thailand Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Malaysia Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Philippines Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Latin America Rare Hematology Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 45. Mexico Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Brazil Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Argentina Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Rare Hematology Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Turkey Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Saudi Arabia Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.A.E Rare Hematology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Takeda Revenue Growth Rate in Rare Hematology Business (2017-2022)
    Figure 53. Novo Nordisk A/S Revenue Growth Rate in Rare Hematology Business (2017-2022)
    Figure 54. Pfizer Inc. Revenue Growth Rate in Rare Hematology Business (2017-2022)
    Figure 55. Bayer Healthcare AG Revenue Growth Rate in Rare Hematology Business (2017-2022)
    Figure 56. CSL Behring LLC Revenue Growth Rate in Rare Hematology Business (2017-2022)
    Figure 57. Biogen Inc. Revenue Growth Rate in Rare Hematology Business (2017-2022)
    Figure 58. Alexion Pharmaceuticals Revenue Growth Rate in Rare Hematology Business (2017-2022)
    Figure 59. Celgene Corporation Revenue Growth Rate in Rare Hematology Business (2017-2022)
    Figure 60. Amgen Inc. Revenue Growth Rate in Rare Hematology Business (2017-2022)
    Figure 61. PRA Health Sciences Revenue Growth Rate in Rare Hematology Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takeda
Novo Nordisk A/S
Pfizer Inc.
Bayer Healthcare AG
CSL Behring LLC
Biogen Inc.
Alexion Pharmaceuticals
Celgene Corporation
Amgen Inc.
PRA Health Sciences
Frequently Asked Questions
Rare Hematology report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rare Hematology report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rare Hematology report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Molybdenum Sheet

Molybdenum Sheet market is segmented by region (country), players, by Type and by Application. Pl ... Read More

Digital Humidifier

Digital Humidifier market is segmented by region (country), players, by Type and by Application.  ... Read More